HOME >> BIOLOGY >> NEWS
Hebrew University, German and British researchers develop means to help stress sufferers

Try as we may to suppress memories of highly stressful experiences, they nevertheless come back to bother us even causing attacks of intense fear or other undesirable behavioral impairments.

Now, a group of German, Israeli and British scientists and students have found that a gene-based approach offers promise for development of a treatment that can suppress these reactions, while not impairing memory itself.

In an article appearing as the cover story in the current issue of Molecular Psychiatry, a team of researchers from the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem and the Max Planck Institute for Experimental Medicine in Goettingen, Germany, describe their work with mice who were subjected to stressful conditions.

The team discovered that this stress induces a change in the expression of the acetylcholinesterase gene. Under normal circumstances, this gene produces a vital protein that adheres to neuronal synapses (the interaction sites through which nerve cells communicate with each other). Following stress, however, the same gene produces large quantities of a protein with modified properties that results in heightened electrical signals in the nerve cells communicating through these synapses. The effect is to create reactions of extreme fright or immobilizing shock.

Later encounter with a context which arouses those stressful memories which might be an object, a sound, an image or other form of association -- can set off that same neuronal reaction. Often, this reaction can have serious consequences, such as chronic fatigue or personality disorders, including post- traumatic stress disorder (PTSD). In the U.S., it is estimated that more than 15 million people a year are identified with PTSD or other anxiety disorders.

The research team at the Hebrew University and in Germany and Britain has succeeded in developing an "antisense" agent that acts to neutralize the process whereby the modified pro
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-2904
The Hebrew University of Jerusalem
11-Dec-2003


Page: 1 2

Related biology news :

1. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
2. Defensive action by influenza viruses demonstrated by Hebrew university researcher
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Scientists in Germany and Hebrew University illuminate process in control of flowering in plants
5. Hebrew University young researcher award goes to Dr. Nayef Jarrous
6. Hebrew University Ph.D. graduate wins young scientist prize in US
7. Hebrew University researcher studies reorganization of brain in blind people
8. Hebrew University researchers develop method to improve neutraceutical absorption
9. Faster method for growing adult stem cells for bone regeneration developed at Hebrew University
10. Hebrew University researcher wins prize for work leading to new anti-cancer drugs
11. Hebrew University excavations strengthen dating of archaeological findings to David, Solomon

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2018)... ... July 31, 2018 , ... GSL Biotech ... with LabArchives , the leading cloud-based Electronic Lab Notebook (ELN) platform. , ... researchers to store all of their research data records in a secure, compliant online ...
(Date:7/29/2018)... ... 29, 2018 , ... Dr. William Plikerd, an evidence-based energy healer, today announces ... immunity and to combat inflammation and autoimmune disorders. , The preclinical research assessed ... reported:, Up to 260% increase overall immunity as seen ...
(Date:7/26/2018)... ... July 25, 2018 , ... Boston Biotech Conferences will ... 4, 2018 at The Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides ... and dissect the most relevant deals in biotech. , George Golumbeski recently joined ...
Breaking Biology News(10 mins):
(Date:8/7/2018)... ... August 06, 2018 , ... Slone Partners, ... the placement of Dr. Paul Harney as President, North America at Prescient Healthcare ... and enhancing client satisfaction. He was also named to Prescient’s Board of Directors. ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... years, announces the launch of their new website. The new website has been ... the site. Mahoney partnered with Proceed Innovative to build a website created for ...
(Date:7/25/2018)... ... July 25, 2018 , ... Vium, Inc. ... Digital Vivariumâ„¢ and Vium Cloud approach to accelerate preclinical drug discovery and development, ... the company announced the appointment of Jeff Caron to the newly formed role ...
(Date:7/24/2018)... ... July 24, 2018 , ... R3 Stem Cell is now offering regenerative therapies ... offered by Double Board Certified providers, with outcomes significantly improving patient quality of life. ... have done nothing to help repair and regenerate damaged lung tissues. Stem cell ...
Breaking Biology Technology:
Cached News: